USA flag logo/image

An Official Website of the United States Government

THERMOPLASTIC POLYURETHANE WITH ENHANCED BIOSTABILITY

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
54027
Program Year/Program:
2001 / SBIR
Agency Tracking Number:
1R43HL064424-01A2
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Zylon Corporation
Zylon Corporation 600 Chestnut Ridge Rd Chestnut Ridge, NY 10977-0231
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2001
Title: THERMOPLASTIC POLYURETHANE WITH ENHANCED BIOSTABILITY
Agency: HHS
Contract: N/A
Award Amount: $100,000.00
 

Abstract:

DESCRIPTION (Verbatim From Applicant's Abstract): Our novel and innovative approach for improving the biostability of thermoplastic polyurethane Consists of chemically modifying tpu and crosslinking it with electron beam radiation. The objective of this Phase I proposal is to evaluate, using a combination of in vivo and in vitro studies, the degree to which this innovative approach improves the biostability of TPU. An improvement in the blostability of TPU would have wide application in biomedical devices especially in Cardiac Pacemakers. Cardiac pacemakers are medical devices, which regulate cardiac rhythmic disorders. Pacemakers comprise a generator, connected to an insulated lead, which is implanted in the heart. Electrical pulses transmitted via the lead are timed to stimulate the heart muscle in a regulated manner. Pacemaker failures may result from deterioration of the pacemaker lead wire insulation. A tailed lead must be surgically replaced. The availability of a cardiac pacemaker wire insulation with increased implant lifetime would be of great value to the medical profession, Such improved leads would eliminate or greatly reduce the requirement for costly and risky surgical lead replacement procedures. A successful demonstration of increased biostability of cross-linked tpu would encourage commercialization of pacemakers utilizing crosslinked tpu insulated leads. PROPOSED COMMERCIAL APPLICATION: Potential commercial applications include pacemaker leads, Vascular grafts, Artifical hearts, Neurological leads, Arterio-venous dialysis shunts, Implantable defibrillators, Wound dressings, Cardiac catheter, Urethral catheters Mammary prostheses, IV bags and tubing, Chemotherapy tubing, Joint protheses, Cardiac valves, and cardiac assist devices such as aortic balloon pumps.

Principal Investigator:

Alan M. Zamore

Business Contact:


9144259469
AZAMORE@ZYLON.COM
Small Business Information at Submission:

ZYLON CORPORATION
600 D RTE 45 CHESTNUT RIDGE, NY 10977

EIN/Tax ID: 113131087
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No